113617-63-3C[C@@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1QIPQASLPWJVQMH-DTORHVGOSA-NOrbifloxacin is a member of quinolines.
113617-63-3FDA approved animal drugs -> Active ingredient
Pharmaceuticals -> UK Veterinary Medicines Directorate List
196.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
206.1 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]
199.41 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 46 reports by companies from 2 notifications to the ECHA C&L Inventory.
Usesantibacterial
UsesOrbifloxacin is a fluoroquinolone antibiotic used in veterinary medicine, mainly for the treatment of staphylococcal infections in dogs.
DefinitionChEBI: Orbifloxacin is a member of quinolines.
DTXSID7046201CHEMBL295433CHEBI:183823